| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.35 | 1e-11 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.29 | 2e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.32 | 9e-10 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |